Human plasma fatty acid composition: the features of hyperlipoproteinemia and the influence of  -linolenate and clofibrate.
D000328:Adult; D000368:Aged; D001796:Blood Protein Disorders / Q000097:blood*; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000097:blood; D005227:Fatty Acids / Q000097:blood*; D005228:Fatty Acids, Essential / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood; D006973:Hypertension / Q000097:blood; D008041:Linoleic Acids / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000097:blood; D010743:Phospholipids / Q000097:blood; D014280:Triglycerides / Q000097:blood
D005227:Fatty Acids; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D008074:Lipoproteins; D010713:Phosphatidylcholines; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate